Literature DB >> 2428417

Conformations of gramicidin A and its 9,11,13,15-phenylalanyl analog in dimethyl sulfoxide and chloroform.

F Heitz, A Heitz, Y Trudelle.   

Abstract

In order to understand the difference in single channel behavior of gramicidin A as compared to that of gramicidin M- which is the mirror image of gramicidin M (all four tryptophanyl residues substituted by phenylalanine), conformational investigations were made under several experimental conditions. It is shown that, when examined under identical conditions, both molecules adopt the same conformations which could be identified in dimethyl sulfoxide (DMSO) and chloroform. In DMSO the conformation is based on a succession of beta-turns while in chloroform gramicidin A and M- can adopt a dimeric hybrid structure: a double helix terminated by two single-stranded helices involving the N- and C-terminal parts, respectively. It is therefore concluded that the difference in the energy profile between both gramicidins which was deduced from the ion transfer data has its origin in the nature of the aromatic side chains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428417     DOI: 10.1016/0301-4622(86)80008-4

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  3 in total

1.  Solvent effects on the conformation of the transmembrane peptide gramicidin A: insights from electrospray ionization mass spectrometry.

Authors:  M Bouchard; D R Benjamin; P Tito; C V Robinson; C M Dobson
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

2.  The double pi pi 5.6 helix of gramicidin A predominates in unsaturated lipid membranes.

Authors:  S V Sychev; L I Barsukov; V T Ivanov
Journal:  Eur Biophys J       Date:  1993       Impact factor: 1.733

3.  The conformation of linear gramicidin is sequence dependent. A monolayer and infrared study.

Authors:  N Van Mau; B Bonnet; A Benayad; F Heitz
Journal:  Eur Biophys J       Date:  1994       Impact factor: 1.733

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.